A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits totaling more than $2 billion circulated online in August 2025.  Claims of lawsuits against Ozempic and similar drugs are indeed true.

As Novo Nordisk transitions from the leadership of longtime CEO Lars Fruergaard Jørgensen to newly appointed chief Maziar Mike Doustdar, the company isn't making a point to rapidly add staffers.

Data to highlight the impact of Wegovy® (semaglutide 2.4 mg) on atrial fibrillation – a common heart rhythm condition – in people living with obesity (SELECT study)Additional Rybelsus® and Ozempic® da

The legal battle over Ozempic is getting bigger by the day. Multiple lawsuits have been filed against the diabetes-medicine-turned weight-loss drug. What started as scattered complaints has grown into more than a thousand lawsuits against Novo Nordisk.

After Novo Nordisk revealed Ozempic will retail for half-price at 70,000 pharmacies throughout the US, people are questioning its ethics